Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir

NCT02442700 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HIV
Dyslipidemia

Interventions

DRUG: pitavastatin
DRUG: placebo

Sponsor

Ramathibodi Hospital